Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Clinical and Laboratory Variables in Heart Failure Patients with Reduced Left Ventricular Ejection Fraction in a Latin American Hospital: A Retrospective Study

Author:

Speranza-Sánchez Mario Osvaldo1,Díaz-Madriz José Pablo1,Zavaleta-Monestel Esteban1ORCID,Chaverri-Fernández José Miguel2ORCID,Arguedas-Chacón Sebastián1,Blanco-Jara Marleny1,Fallas-Mora Abigail1,Velásquez-Alfaro Luis Daniel2

Affiliation:

1. Heart Failure Clinic, Hospital Clínica Biblica, San Jose 1307-1000, Costa Rica

2. Department of Pharmacology, Toxicology and Pharmacodependence, University of Costa Rica, San José 2060-1000, Costa Rica

Abstract

Heart failure (HF) is a syndrome suffered by more than 26 million people worldwide. SGLT2 inhibitors are drugs that have been shown to positively affect the management of HF patients, regardless of their diabetes status. A retrospective observational study was conducted on heart failure patients with reduced ejection fraction (HFrEF) enrolled at the HF clinic, who were on SGLT2 inhibitors. For these patients, baseline and follow-up data were collected and analyzed over time. Changes over time were quantified and statistical analysis was conducted to validate whether the changes were significant. After the screening of all the HF program patients, 24 met the inclusion criteria, with an average age of 68 years. Through the study, it was possible to find a statistically significant difference in the values of NT-ProBNP before and after adding a SGLT2 inhibitor in 14 patients (p = 0.0214). In addition, there was an improvement in the NYHA functional scale of 71% and no significant change in renal function or other laboratory values. Based on the studied parameters and throughout the clinical changes during the follow-up period, it was possible to establish an improvement in HFrEF patients on SGLT2 inhibitors as part of their therapy.

Publisher

MDPI AG

Subject

General Medicine

Reference33 articles.

1. Heart Failure with Reduced Ejection Fraction;Bloom;Nat. Rev. Dis. Prim.,2017

2. SGLT2 Inhibition and Heart Failure—Current Concepts;Custodio;Heart Fail. Rev.,2018

3. Interamerican Society of Cardiology The Reality of Heart Failure in Latin America;Bocchi;J. Am. Coll. Cardiol.,2013

4. Efecto Del Sacubitril/Valsartan Sobre Las Variables Clínicas, de Laboratorio y Ecocardiográficas Utilizadas Para El Control de La Insuficiencia Cardíaca Con Fracción de Eyección Del Ventrículo Izquierdo Reducida (FEVIr) de Los Pacientes Activos Del Programa de Insuficiencia Cardíaca (PIC) Del Hospital Clínica Bíblica;Blanco;Rev. Costarric. Cardiol.,2020

5. Primer Consenso Centroamericano y El Caribe de Sociedades de Cardiología Para El Diagnóstico y Manejo de La Falla Cardíaca;Paulino;Rev. Costarric. Cardiol.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3